Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease

Journal of Physiology

Volumn 525, Issue 2, 2000, Pages 433-445

  Vanselow, Bodo K ^a   Keller, Bernhard U ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CALCIUM CHANNEL; CALCIUM ION; DYE;

ADAPTATION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DEPOLARIZATION; ELECTRIC POTENTIAL; HYPOGLOSSAL NUCLEUS; MICROFLUOROMETRY; MOTONEURON; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; OCULOMOTOR NUCLEUS; PATCH CLAMP; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD; TEMPERATURE; ACTION POTENTIAL AMPLITUDE; DISEASE RESISTANCE; IN VITRO STUDY; NERVE CELL DEGENERATION; NERVE CELL MEMBRANE STEADY POTENTIAL; OCULOMOTOR NERVE; QUANTITATIVE ANALYSIS; SPINAL CORD MOTONEURON;

EID: 0034212794     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-7793.2000.t01-1-00433.x     Document Type: Article

References (64)

1. ABDEL-HAMID, K. M. & BAIMBRIDGE, K. G. (1997). The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons. Neuroscience 81, 673-687.
2. ALEXIANU, M. E., HO, B. K., MOHAMED, A. H., LA, B. V., SMITH, R. G. & APPEL, S. H. (1994). The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Annual Neurology 36, 846-858.
3. ALEXIANU, M. E., ROBBINS, E., CARSWELL, S. & APPEL, S. H. (1998). 1α,25 dihydroxyvitamin D3-dependent upregulation of calcium-binding proteins in motoneuron cells. Journal of Neuroscience Resarch 51, 58-66.
4. APPEL, S. H., SMITH, R. G., ALEXIANU, M.. SIKLOS, L., ENGELHARDT, J., COLOM, L. V. & STEFANI, E. (1995). Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral selerosis. Clinical Neuroscience 3, 368-374.
5. BAIMBRIDGE, K. G., CELIO, M. R. & ROGERS, J. H. (1992). Calcium binding proteins in the nervous system. Trends in Neurosciences 15, 303-308.
6. BAR-PELED, O., O'BRIEN, R. J., MORRISON, J. H. & ROTHSTEIN, J. D. (1999). Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. NeuroReport 10, 855-859.
7. BLAUSTEIN, M. P. (1988). Calcium transport and buffering in neurons. Trends in Neurosciences 11, 438-443.
8. BRUIJN, L. I., HOUSEWAERT, M. K., KATO, S., ANDERSON, K. L., ANDERSON, S. D., OHAMA, E., REAUME, A. G., SCOTT, R. W. & CLEVELAND, D. W. (1998). Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851-1854.
9. 2+ overload and ROS generation in spinal motor neurones in vitro. Journal of Neuroscience 20, 240-250.
10. CARRIEDO, S. G., YIN, H. Z. & WEISS, J. H. (1996). Motor neurones are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. Journal of Neuroscience 16, 4069-4079.
11. CHAD, J. (1989). Inactivation of calcium channels. Comparative Biochemistry and Physiology A 93, 95-105.
12. CHOI, D. W. (1987). Ionic dependence of glutamate neurotoxicity. Journal of Neuroscience 7, 369-379.
13. CHOI, D. W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
14. CLEVELAND, D. W. (1999). From charcot to SOD1: Mechanisms of selective motor neuron death in ALS. Neuron 24, 515-520.
15. DEPAUL, R., ABBS, J. H., CALIGIURI, M., GRACCO, V. L. & BROOKS, B. R. (1988). Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38, 281-283.
16. EDWARDS, F. A., KONNERTH, A., SAKMANN, B. & TAKAHASHI, T. (1989). A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflügers Archiv 414, 600-612.
17. ELLIOT, J. L. & SNIDER, W. D. (1995). Parvalbumin is a marker of ALS-resistant motor neurons. NeuroReport 6, 449-452.
18. FIERRO, L. & LLANO, I. (1996). High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. Journal of Physiology 496, 617-625.
19. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 260, 3440-3450.
20. GURNEY, M. E., CUTTINGS, F. B., ZHAI, P., DOBLE, A., TAYLOR, C. P., ANDRUS, P. K. & HAL, E. D. (1996). Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Annual Neurology 39, 147-157.
21. HELMCHEN, F., BORST, J. G. & SAKMANN, B. (1997). Calcium dynamics associated with a single action potential in a CNS presynaptic terminal. Biophysical Journal 72, 1458-1471.
22. 2+ signaling in dendrites of pyramidal neurons. Biophysical Journal 70, 1069-1081.
23. HO, B. K., ALEXIANU, M. E., COLOM, L. V., MOHAMED, A. H., SERRANO, F. & APPEL, S. H. (1996). Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K. cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proceedings of the National Academy of Sciences of the USA 93, 6796-6801.
24. INCE, P., STOUT, N., SHAW, P., SLADE, J., HUNZIKER, W., HEIZMANN, C. W. & BAIMBRIDGE, K. G. (1993). Parvalbumin and calbindin D-28k in the human motor system and in motoneuron disease. Neuropathology and Applied Neurobiology 19, 291-299.
25. KELLER, B. U., KONNERTH, A. & YAARI, Y. (1991). Patch clamp analysis of excitatory synaptic currents in granule cells of rat hippocampus. Journal of Physiology 435, 275-293.
26. KLAPSTEIN, G. J., VIETLA, S., LIEBERMAN, D. N., GRAY, P. A., AIRAKSINEN, M. S., THOENEN, H., MEYER, M. & MODY, I. (1998). Calbindin-D28 fails to protect hippocampal neurons against ischemia in spite of its cytoplasmic calcium buffering properties: evidence from calbindin-D28k knockout mice. Neuroscience 85, 361-373.
27. 2+ diffusion near the membrane: implications for secretion in neuroendocrine cells. Biophysical Journal 72, 674-690.
28. KLIVENYI, P., FERRANTE, R. J., MATTHEWS, R. T., BOGDANOV, M. B., KLEIN, A. M., ANDREASSEN, O. A., MUELLER, G., WERMER, M., KADDURAH-DAOUK, R., BEAL, M. F. (1999). Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine 5, 347-350.
29. KRIEGER, C., JONES, K., KIM, S. U. & EISEN, A. A. (1994). The role of intracellular free calcium in motor neuron disease. Journal of the Neurological Sciences 124, 27-32.
30. 2+ and protein kinase C. Trends in Pharmacological Sciences 17, 114-120.
31. LADEWIG, T. & KELLER, B. U. (1998). Calcium imaging in rhythmically active motoneurones in the nucleus hypoglossus from mouse. Pflügers Archiv 435, R62.
32. LIPS, M. B. & KELLER, B. U. (1998). Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouse. Journal of Physiology 511, 105-117.
33. LIPS, M. B. & KELLER, B. U. (1999). Activity-related calcium dynamics in motoneurones of the nucleus hypoglossus from mouse. Journal of Neurophysiology 82, 2936-2946.
34. MCBURNEY, R. N. & NEERING, I. R. (1987). Neuronal calcium homeostasis. Trends in Neurosciences 10, 164-169.
35. MCMAHON, A., WONG, B. S., IACOPINO, A. M., NG, M. C., CHI, S. & GERMAN, D. C. (1998). Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Molecular Brain Research 54, 56-63.
36. MEDINA, L., FIGUEREDO, C. G., ROTHSTEIN, J. D. & REINER, A. (1996). Differential abundance of glutamate transporter subtypes in amyotrophic lateral scleroses (ALS)-vulnarable versus ALS-resistant brain stem motor cell groups. Experimental Neurology 142, 287-295.
37. MELDRUM, B. & GARTHWAITE, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends in Pharmacological Sciences 11, 379-387.
38. MORRISON, B. M. & MORRISON, J. H. (1998). Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration. Brain Research Reviews 29, 121-135.
39. NÄGERL, U. V. & MODY, I. (1998). Calcium-dependent inactivation of high-threshold calcium currents in human dentate gyrus granule cells. Journal of Physiology 509, 39-45.
40. NEHER, E. (1986). Concentration profiles of intracellular calcium in the presence of a diffusable chelator. Experimental Brain Research, 14, 80-96.
41. 2+ fluxes. Neuropharmacology 34, 1423-1442.
42. 2+ signals. Cell Calcium 24, 345-357.
43. NEHER, E. & AUGUSTINE, G. J. (1992). Calcium gradients and buffers in bovine chromaffin cells. Journal of Physiology 450, 273-301.
44. PALECEK, J., LIPS, M. B. & KELLER, C. U. (1999). Calcium dynamics and buffering in motoneurons of the mouse spinal cord. Journal of Physiology 520, 485-502.
45. REINER, A., MEDINA, L., FIGUEREDO, C. G. & ANFINSON, S. (1995). Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral selerosis are preferentially enriched in parvalbumin: evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS. Experimental Neurology 131, 239-250.
46. ROBERTS, W. M. (1994). Localization of calcium signals by a mobile calcium buffer in frog saccular hair cells. Journal of Neuroscience 14, 3246-3262.
47. ROTHSTEIN, J. D., KAMMEN, M. VAN., LEVEY, A. I., MARTIN, L. J. & KUNCL, R. W., (1995). Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Annual Neurology 38, 73-84.
48. ROTHSTEIN, J. D. & KUNCL, R. W. (1995). Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. Journal of Neurochemistry 65, 643-651.
49. ROTHSTEIN, J. D., MARTIN, L. J. & KUNCL, R. W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New England Journal of Medicine 326, 1464-1468.
50. ROY, J., MINOTTI, S., DONG, L., FIGLEWICZ, D. D. & DURHAM, H. D. (1998). Glutamate potentiates the toxicity of mutant Cu/Zn -superoxide dismutase in motor neurones by postsynaptic calcium-dependent mechanisms. Journal of Neuroscience 18, 9673-9684.
51. SHAW, P. J. & INCE, P. G. (1997). Glutamate, excitotoxicity and amyotrophic lateral sclerosis. Journal of Neurology 244, 3-14.
52. SHAW, P. J., WILLIAMS, T. L., SLADE, J. Y., EGGETT, E. Y. & INCE, P. G. (1999). Low expression of GluR2 Ampa receptor subunit protein by human motor neurons. NeuroReport 10, 261-265.
53. SIKLOS, L., ENGELHARDT, G. I., ALEXIANU, M. E., SIDDIQUE, T. & APPEL, S. H. (1998). Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice. Journal of Neuropathology and experimental Neurology 57, 571-587.
54. SMITH, R. G., HAMILTON, S., HOFMANN, F., SCHNEIDER, T., NASTAINCZYK, W., BIRNBAUMER, L., STEFANI, E. & APPEL, S. H. (1992). Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. New England Journal of Medicine 327, 1721-1728.
55. 2+ channels: diversity of form and function. Current Opinion in Neurobiology 2, 24-253.
56. STUART, G. J., DODT, H. U. & SAKMANN, B. (1993). Patch clamp recordings from the soma and dendrites of neurones in brain slices using infrared video microscopy. Pflügers Archiv 423, 511-518.
57. TITZ, S. & KELLER, B. U. (1997). Rapidly deactivating AMPA receptors determine excitatory synaptic transmission to interneurons in the nucleus tractus solitarius from rat. Journal of Neurophysiology 78, 82-91.
58. TROTTI, D., ROLFS, A., DANBOLT, N. C., BROWN, R. H. JR & HEDIGER, M. A. (1999). SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nature Neuroscience 2, 427-433.
59. TU, P. H., RAJU, O., ROBINSON, K. A., GURNEY, M. E., TROJANOWSKI, J. Q. & LEE, M. Y. (1996). Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proceedings of the National Academy of Science of the USA 93, 3155-3160.
60. 1 and glutamate neurotoxicity in vitro. Journal of Neurophysiology 72, 1973-1992.
61. VANDENBERGHE, W., ROBBERECHT, W. & BRORSON, J. R. (2000). AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. Journal of Neurscience 20, 123-132.
62. WILLIAMSON, T. L., BRUIJN, L. I., ZHU, Q., ANDERSON, K. L., ANDERSON, S. D., JULIEN, J. & CLEVELAND, D. W. (1998). Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proceedings of the National Academy of Sciences of the USA 95, 9631-9636.
63. ZHOU, Z. & NEHER, E. (1993a). Calcium permeability of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells. Pflügers Archiv 425, 511-517.
64. ZHOU, Z. & NEHER, E. (1993b). Mobile and immobile calcium buffers in bovine adrenal cells. Journal of Physiology 469, 245-273.